CARLSBAD, CALIFORNIA--(Marketwired - April 3, 2014) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it will be participating at the 13th Annual Needham Healthcare Conference on April 8th and 9th in New York City.
Aurora Spine is scheduled to present together with approximately 120 companies in the biotechnology, specialty pharmaceutical, medical technology and diagnostic sectors. The presenters will include a selection of leading private companies. Needham's Healthcare Conference focuses on connecting emerging life science companies and investors.
"We look forward to participating in the 13th Annual Needham Healthcare Conference. It is an honor and privilege to present at this year's conference," said Eric Fronk, Chief Financial Officer of Aurora Spine. "I'm excited to share our company vision and mission in providing advanced spinal technologies in the medical industry. This forum will give us an opportunity to display our latest products and technologies."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of Aurora Spine's products. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.